Methocarbamol
Tablet · Oral, Intravenous, Intramuscular
Uses
Methocarbamol Tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.
Dosage and administration
Methocarbamol Tablets, USP, 500 mg – Adults: Initial dosage: 3 tablets four times daily Maintenance dosage: 2 tablets four times daily Methocarbamol Tablets, USP, 750 mg – Adults: Initial dosage: 2 tablets four times daily Maintenance dosage: 1 tablet every 4 hours or 2 tablets three times daily Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered.) Thereafter, the dosage can usually be reduced to approximately 4 grams a day.
Contraindications
Methocarbamol Tablets, USP are contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components.
Warnings
Since methocarbamol may possess a general CNS depressant effect, patients receiving Methocarbamol Tablets, USP should be cautioned about combined effects with alcohol and other CNS depressants. Safe use of Methocarbamol Tablets, USP has not been established with regard to possible adverse effects upon fetal development. There have been reports of fetal and congenital abnormalities following in utero exposure to methocarbamol. Therefore, Methocarbamol Tablets, USP should not be used in women who are or may become pregnant and particularly during early pregnancy unless in the judgment of the physician the potential benefits outweigh the possible hazards. Use in Activities Requiring Mental Alertness Methocarbamol may impair mental and/or physical abilities required for performance of hazardous tasks, such as operating machinery or driving a motor vehicle. Patients should be cautioned about operating machinery, including automobiles, until they are reasonably certain that methocarbamol therapy does not adversely affect their ability to engage in such activities.
Precautions
Information for Patients Patients should be cautioned that methocarbamol may cause drowsiness or dizziness, which may impair their ability to operate motor vehicles or machinery. Because methocarbamol may possess a general CNS-depressant effect, patients should be cautioned about combined effects with alcohol and other CNS depressants. Drug Interactions See WARNINGS and PRECAUTIONS for interaction with CNS drugs and alcohol. Methocarbamol may inhibit the effect of pyridostigmine bromide. Therefore, methocarbamol should be used with caution in patients with myasthenia gravis receiving anticholinesterase agents. Drug/Laboratory Test Interactions Methocarbamol may cause a color interference in certain screening tests for 5-hydroxyindoleacetic acid (5-HIAA) using nitrosonaphthol reagent and in screening tests for urinary vanillylmandelic acid (VMA) using the Gitlow method. Carcinogenesis, Mutagenesis, Impairment of Fertility Long-term studies to evaluate the carcinogenic potential of methocarbamol have not been performed. No studies have been conducted to assess the effect of methocarbamol on mutagenesis or its potential to impair fertility. Pregnancy Teratogenic Effects Animal reproduction studies have not been conducted with methocarbamol. It is also not known whether methocarbamol can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Methocarbamol Tablets, USP should be given to a pregnant woman only if clearly needed. Safe use of Methocarbamol Tablets, USP has not been established with regard to possible adverse effects upon fetal development. There have been reports of fetal and congenital abnormalities following in utero exposure to methocarbamol. Therefore, Methocarbamol Tablets, USP should not be used in women who are or may become pregnant and particularly during early pregnancy unless in the judgment of the physician the potential benefits outweigh the possible hazards (see WARNINGS ). Nursing Mothers Methocarbamol and/or its metabolites are excreted in the milk of dogs; however, it is not known whether methocarbamol or its metabolites are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Methocarbamol Tablets, USP are administered to a nursing woman. Pediatric Use Safety and effectiveness of Methocarbamol Tablets, USP in pediatric patients below the age of 16 have not been established.
Side effects
Adverse reactions reported coincident with the administration of methocarbamol include: Body as a whole: Anaphylactic reaction, angioneurotic edema, fever, headache Cardiovascular system: Bradycardia, flushing, hypotension, syncope, thrombophlebitis Digestive system: Dyspepsia, jaundice (including cholestatic jaundice), nausea and vomiting Hemic and lymphatic system: Leukopenia Immune system: Hypersensitivity reactions Nervous system: Amnesia, confusion, diplopia, dizziness or lightheadedness, drowsiness, insomnia, mild muscular incoordination, nystagmus, sedation, seizures (including grand mal), vertigo Skin and special senses: Blurred vision, conjunctivitis, nasal congestion, metallic taste, pruritus, rash, urticaria
Drug interactions
Drug Interactions See WARNINGS and PRECAUTIONS for interaction with CNS drugs and alcohol. Methocarbamol may inhibit the effect of pyridostigmine bromide. Therefore, methocarbamol should be used with caution in patients with myasthenia gravis receiving anticholinesterase agents.
Pregnancy
Pregnancy Teratogenic Effects Animal reproduction studies have not been conducted with methocarbamol. It is also not known whether methocarbamol can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Methocarbamol Tablets, USP should be given to a pregnant woman only if clearly needed. Safe use of Methocarbamol Tablets, USP has not been established with regard to possible adverse effects upon fetal development. There have been reports of fetal and congenital abnormalities following in utero exposure to methocarbamol. Therefore, Methocarbamol Tablets, USP should not be used in women who are or may become pregnant and particularly during early pregnancy unless in the judgment of the physician the potential benefits outweigh the possible hazards (see WARNINGS ).
Pediatric use
Pediatric Use Safety and effectiveness of Methocarbamol Tablets, USP in pediatric patients below the age of 16 have not been established.
Overdosage
Limited information is available on the acute toxicity of methocarbamol. Overdose of methocarbamol is frequently in conjunction with alcohol or other CNS depressants and includes the following symptoms: nausea, drowsiness, blurred vision, hypotension, seizures, and coma. In post-marketing experience, deaths have been reported with an overdose of methocarbamol alone or in the presence of other CNS depressants, alcohol or psychotropic drugs. Treatment Management of overdose includes symptomatic and supportive treatment. Supportive measures include maintenance of an adequate airway, monitoring urinary output and vital signs, and administration of intravenous fluids if necessary. The usefulness of hemodialysis in managing overdose is unknown.
Description
Methocarbamol Tablets, USP, a carbamate derivative of guaifenesin, is a central nervous system (CNS) depressant with sedative and musculoskeletal relaxant properties. The chemical name of methocarbamol is 3-(2-methoxyphenoxy)-1,2-propanediol 1-carbamate and has the empirical formula C11H15NO5. Its molecular weight is 241.24. The structural formula is shown below. Methocarbamol is a white powder, sparingly soluble in water and chloroform, soluble in alcohol (only with heating) and propylene glycol, and insoluble in benzene and n -hexane. Methocarbamol Tablets, USP 500 mg are available as a white, round, scored, film-coated tablet containing 500 mg of methocarbamol, USP for oral administration. The inactive ingredients present are microcrystalline cellulose, croscarmellose sodium, povidone (k-30), sodium lauryl sulfate, colloidal silicon dioxide, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol, polysorbate 80. Methocarbamol Tablets, USP 750 mg are available as a white, capsule-shaped, film-coated tablet containing 750 mg of methocarbamol, USP for oral administration. The inactive ingredients present are microcrystalline cellulose, croscarmellose sodium, povidone (k-30), sodium lauryl sulfate, colloidal silicon dioxide, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol, polysorbate 80. structure.jpg
How supplied
Methocarbamol Tablets, USP, 500 mg tablets are white, round, film-coated tablets. They are supplied as follows: Bottles of 90 NDC 82461-0722-90 Methocarbamol Tablets, USP, 750 mg tablets are white, capsule-shaped, film-coated tablets. They are supplied as follows: Bottles of 90 NDC 82461-0723-90 Store at 20º to 25º C (68º to 77º F) [see USP Controlled Room Temperature]. For 100 count, Dispense contents in a tight container with child-resistant closure. For 500 count, Dispense contents in a tight container.
Patient information
Information for Patients Patients should be cautioned that methocarbamol may cause drowsiness or dizziness, which may impair their ability to operate motor vehicles or machinery. Because methocarbamol may possess a general CNS-depressant effect, patients should be cautioned about combined effects with alcohol and other CNS depressants.
Label text from the FDA structured product label by Medcore LLC (revised Jul 29, 2026). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Methocarbamol in 198 products
Methocarbamol NDC products (198)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 50090-5846 | Methocarbamol 500 mg/1 Tablet | A-S Medication Solutions | ANDA |
| 50090-3570 | Methocarbamol 500 mg/1 Tablet, Coated | A-S Medication Solutions | ANDA |
| 50090-3557 | Methocarbamol 500 mg/1 Tablet, Coated | A-S Medication Solutions | ANDA |
| 50090-3556 | Methocarbamol 750 mg/1 Tablet, Coated | A-S Medication Solutions | ANDA |
| 50090-1783 | Methocarbamol 750 mg/1 Tablet | A-S Medication Solutions | ANDA |
| 50090-1781 | Methocarbamol 750 mg/1 Tablet | A-S Medication Solutions | ANDA |
| 50090-0184 | Methocarbamol 500 mg/1 Tablet | A-S Medication Solutions | ANDA |
| 50090-0183 | Methocarbamol 500 mg/1 Tablet | A-S Medication Solutions | ANDA |
| 50090-0182 | Methocarbamol 500 mg/1 Tablet | A-S Medication Solutions | ANDA |
| 50090-3578 | Methocarbamol 500 mg/1 Tablet, Film Coated | A-S Medication Solutions | ANDA |
| 50090-3587 | Methocarbamol 750 mg/1 Tablet, Coated | A-S Medication Solutions | ANDA |
| 50090-3756 | Methocarbamol 500 mg/1 Tablet, Coated | A-S Medication Solutions | ANDA |
| 50090-4793 | Methocarbamol 500 mg/1 Tablet, Film Coated | A-S Medication Solutions | ANDA |
| 50090-5006 | Methocarbamol 750 mg/1 Tablet | A-S Medication Solutions | ANDA |
| 50090-5008 | Methocarbamol 750 mg/1 Tablet | A-S Medication Solutions | ANDA |
| 50090-5847 | Methocarbamol 500 mg/1 Tablet | A-S Medication Solutions | ANDA |
| 50090-5907 | Methocarbamol 500 mg/1 Tablet | A-S Medication Solutions | ANDA |
| 80425-0579 | Methocarbamol 500 mg/1 Tablet, Coated | Advanced Rx of Tennessee, LLC | ANDA |
| 80425-0578 | Methocarbamol 500 mg/1 Tablet, Coated | Advanced Rx of Tennessee, LLC | ANDA |
| 80425-0577 | Methocarbamol 500 mg/1 Tablet | Advanced Rx of Tennessee, LLC | ANDA |
| 80425-0490 | Methocarbamol 750 mg/1 Tablet | Advanced Rx of Tennessee, LLC | ANDA |
| 80425-0021 | Methocarbamol 750 mg/1 Tablet | Advanced Rx of Tennessee, LLC | ANDA |
| 80425-0020 | Methocarbamol 750 mg/1 Tablet, Coated | Advanced Rx of Tennessee, LLC | ANDA |
| 80425-0283 | Methocarbamol 500 mg/1 Tablet | Advanced Rx Pharmacy of Tennessee, LLC | ANDA |
| 80425-0275 | Methocarbamol 500 mg/1 Tablet | Advanced Rx Pharmacy of Tennessee, LLC | ANDA |
| 80425-0171 | Methocarbamol 750 mg/1 Tablet, Film Coated | Advanced Rx Pharmacy of Tennessee, LLC | ANDA |
| 80425-0138 | Methocarbamol 500 mg/1 Tablet, Film Coated | Advanced Rx Pharmacy of Tennessee, LLC | ANDA |
| 60687-559 | Methocarbamol 500 mg/1 Tablet | American Health Packaging | ANDA |
| 60687-568 | Methocarbamol 750 mg/1 Tablet | American Health Packaging | ANDA |
| 71610-599 | Methocarbamol 500 mg/1 Tablet | Aphena Pharma Solutions - Tennessee, LLC | ANDA |
| 53401-035 | Methocarbamol 750 mg/1 Tablet | Aphena Pharma Solutions - Tennessee, LLC | ANDA |
| 71610-832 | Methocarbamol 500 mg/1 Tablet | Aphena Pharma Solutions - Tennessee, LLC | ANDA |
| 71610-833 | Methocarbamol 750 mg/1 Tablet | Aphena Pharma Solutions - Tennessee, LLC | ANDA |
| 71610-134 | Methocarbamol 750 mg/1 Tablet, Coated | Aphena Pharma Solutions - Tennessee, LLC | ANDA |
| 71610-174 | Methocarbamol 750 mg/1 Tablet, Film Coated | Aphena Pharma Solutions - Tennessee, LLC | ANDA |
| 71610-598 | Methocarbamol 750 mg/1 Tablet | Aphena Pharma Solutions - Tennessee, LLC | ANDA |
| 87063-689 | Methocarbamol 750 mg/1 Tablet | ASCLEMED USA INC. | ANDA |
| 87063-135 | Methocarbamol 500 mg/1 Tablet | ASCLEMED USA INC. | ANDA |
| 76420-626 | Methocarbamol 500 mg/1 Tablet | Asclemed USA, Inc. | ANDA |
| 76420-258 | Methocarbamol 750 mg/1 Tablet | Asclemed USA, Inc. | ANDA |
| 76420-894 | Methocarbamol 750 mg/1 Tablet, Coated | Asclemed USA, Inc. | ANDA |
| 76420-040 | Methocarbamol 750 mg/1 Tablet, Film Coated | Asclemed USA, Inc. | ANDA |
| 76420-638 | Methocarbamol 750 mg/1 Tablet | Asclemed USA, Inc. | ANDA |
| 87063-040 | Methocarbamol 500 mg/1 Tablet, Film Coated | Asclemed USA, Inc. | ANDA |
| 76420-667 | Methocarbamol 500 mg/1 Tablet | Asclemed USA, Inc. | ANDA |
| 87063-041 | Methocarbamol 750 mg/1 Tablet, Film Coated | Asclemed USA, Inc. | ANDA |
| 76420-893 | Methocarbamol 500 mg/1 Tablet, Coated | Asclemed USA, Inc. | ANDA |
| 59651-341 | Methocarbamol 750 mg/1 Tablet, Film Coated | Aurobindo Pharma Limited | ANDA |
| 59651-340 | Methocarbamol 500 mg/1 Tablet, Film Coated | Aurobindo Pharma Limited | ANDA |
| 50268-521 | Methocarbamol 750 mg/1 Tablet | AvPAK | ANDA |
| 50268-520 | Methocarbamol 500 mg/1 Tablet | AvPAK | ANDA |
| 36000-302 | Methocarbamol 100 mg/mL Injection | Baxter Healthcare Corporation | ANDA |
| 35561-212 | Methocarbamol 500 mg/1 Tablet, Coated | Bostal LLC | ANDA |
| 35561-349 | Methocarbamol 1000 mg/1 Tablet, Coated | Bostal LLC | ANDA |
| 35561-211 | Methocarbamol 750 mg/1 Tablet, Coated | Bostal LLC | ANDA |
| 63629-1123 | Methocarbamol 500 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 63629-1622 | Methocarbamol 500 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 63629-2418 | Methocarbamol 500 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 63629-2419 | Methocarbamol 750 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 63629-2420 | Methocarbamol 750 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 63629-4882 | Methocarbamol 500 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 63629-8995 | Methocarbamol 750 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 63629-9288 | Methocarbamol 500 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 71335-1727 | Methocarbamol 750 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 71335-0970 | Methocarbamol 500 mg/1 Tablet, Film Coated | Bryant Ranch Prepack | ANDA |
| 71335-0909 | Methocarbamol 750 mg/1 Tablet, Coated | Bryant Ranch Prepack | ANDA |
| 71335-0828 | Methocarbamol 750 mg/1 Tablet, Film Coated | Bryant Ranch Prepack | ANDA |
| 71335-0251 | Methocarbamol 750 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 72162-1930 | Methocarbamol 750 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 71335-1795 | Methocarbamol 500 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 71335-2305 | Methocarbamol 750 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 71335-2383 | Methocarbamol 500 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 71335-2794 | Methocarbamol 500 mg/1 Tablet, Film Coated | Bryant Ranch Prepack | ANDA |
| 71335-3105 | Methocarbamol 500 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 71335-2795 | Methocarbamol 750 mg/1 Tablet, Film Coated | Bryant Ranch Prepack | ANDA |
| 72162-1929 | Methocarbamol 500 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 72162-1363 | Methocarbamol 500 mg/1 Tablet | Bryant Ranch Prepack | ANDA |
| 31722-534 | Methocarbamol 750 mg/1 Tablet | Camber Pharmaceuticals, Inc. | ANDA |
| 31722-533 | Methocarbamol 500 mg/1 Tablet | Camber Pharmaceuticals, Inc. | ANDA |
| 55154-2334 | Methocarbamol 500 mg/1 Tablet | Cardinal Health 107, LLC | ANDA |
| 55154-2335 | Methocarbamol 750 mg/1 Tablet | Cardinal Health 107, LLC | ANDA |
| 55154-2130 | Methocarbamol 750 mg/1 Tablet | Cardinal Health 107, LLC | ANDA |
| 55154-2129 | Methocarbamol 500 mg/1 Tablet | Cardinal Health 107, LLC | ANDA |
| 67046-1177 | Methocarbamol 500 mg/1 Tablet | Coupler LLC | ANDA |
| 67046-1147 | Methocarbamol 750 mg/1 Tablet | Coupler LLC | ANDA |
| 67046-0538 | Methocarbamol 500 mg/1 Tablet, Coated | Coupler LLC | ANDA |
| 67046-0340 | Methocarbamol 750 mg/1 Tablet, Coated | Coupler LLC | ANDA |
| 61919-368 | Methocarbamol 500 mg/1 Tablet | DIRECT RX | ANDA |
| 61919-616 | Methocarbamol 750 mg/1 Tablet, Coated | DIRECT RX | ANDA |
| 72189-665 | Methocarbamol 500 mg/1 Tablet | Direct_rx | ANDA |
| 72189-284 | Methocarbamol 500 mg/1 Tablet | DirectRx | ANDA |
| 69306-510 | Methocarbamol 500 mg/1 Tablet | Doc Rx | ANDA |
| 69306-500 | Methocarbamol 500 mg/1 Tablet | Doc Rx | ANDA |
| 43598-839 | Methocarbamol 100 mg/mL Injection | Dr.Reddys Laboratories Inc., | ANDA |
| 55150-223 | Methocarbamol 1000 mg/10mL Injection, Solution | Eugia US LLC | ANDA |
| 72887-873 | Methocarbamol 1000 mg/1 Tablet, Film Coated | FH2 PHARMA LLC | ANDA |
| 63323-778 | Methocarbamol 100 mg/mL Injection, Solution | Fresenius Kabi USA, LLC | ANDA |
| 15014-910 | Methocarbamol 500 mg/1 Tablet | GENTEX PHARMA, LLC | ANDA |
| 68083-317 | Methocarbamol 100 mg/mL Injection | Gland Pharma Limited | ANDA |
| 51407-468 | Methocarbamol 750 mg/1 Tablet | Golden State Medical Supply, Inc. | ANDA |
| 51407-467 | Methocarbamol 500 mg/1 Tablet | Golden State Medical Supply, Inc. | ANDA |
| 62207-754 | Methocarbamol 500 mg/1 Tablet, Coated | Granules India Ltd | ANDA |
| 62207-770 | Methocarbamol 750 mg/1 Tablet, Coated | Granules India Ltd | ANDA |
| 70010-754 | Methocarbamol 500 mg/1 Tablet, Coated | Granules Pharmaceuticals Inc. | ANDA |
| 70010-770 | Methocarbamol 750 mg/1 Tablet, Coated | Granules Pharmaceuticals Inc. | ANDA |
| 85534-0057 | Methocarbamol 500 mg/1 Tablet | HAWAII REPACK, INC. | ANDA |
| 85534-0022 | Methocarbamol 750 mg/1 Tablet | HAWAII REPACK, INC. | ANDA |
| 85534-0021 | Methocarbamol 500 mg/1 Tablet | HAWAII REPACK, INC. | ANDA |
| 0404-9992 | Methocarbamol 1000 mg/10mL Injection, Solution | Henry Schein, Inc | ANDA |
| 86211-114 | Methocarbamol 100 mg/mL Injection | JVET PHARMACEUTICALS LLC | ANDA |
| 70868-901 | Methocarbamol 750 mg/1 Tablet | Key Therapeutics | ANDA |
| 70868-910 | Methocarbamol 500 mg/1 Tablet | Key Therapeutics | ANDA |
| 0904-7058 | Methocarbamol 750 mg/1 Tablet | Major Pharmaceuticals | ANDA |
| 0904-7057 | Methocarbamol 500 mg/1 Tablet | Major Pharmaceuticals | ANDA |
| 82461-723 | Methocarbamol 750 mg/1 Tablet, Film Coated | Medcore LLC | ANDA |
| 82461-722 | Methocarbamol 500 mg/1 Tablet, Film Coated | Medcore LLC | ANDA |
| 45865-242 | Methocarbamol 500 mg/1 Tablet | Medsource Pharmaceuticals | ANDA |
| 71288-716 | Methocarbamol 100 mg/mL Injection, Solution | Meitheal Pharmaceuticals Inc. | ANDA |
| 0276-0510 | Methocarbamol 1000 mg/1 Tablet, Coated | Misemer Pharmaceutical | ANDA |
| 0615-8506 | Methocarbamol 500 mg/1 Tablet, Film Coated | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA |
| 0615-8507 | Methocarbamol 750 mg/1 Tablet, Film Coated | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA |
| 51655-195 | Methocarbamol 500 mg/1 Tablet, Coated | Northwind Health Company, LLC | ANDA |
| 51655-205 | Methocarbamol 750 mg/1 Tablet, Coated | Northwind Health Company, LLC | ANDA |
| 51655-575 | Methocarbamol 750 mg/1 Tablet | Northwind Health Company, LLC | ANDA |
| 51655-574 | Methocarbamol 500 mg/1 Tablet | Northwind Health Company, LLC | ANDA |
| 68071-3636 | Methocarbamol 500 mg/1 Tablet | NuCare Pharmaceuticals, Inc. | ANDA |
| 66267-146 | Methocarbamol 750 mg/1 Tablet | NuCare Pharmaceuticals, Inc. | ANDA |
| 68071-3859 | Methocarbamol 750 mg/1 Tablet, Film Coated | NuCare Pharmaceuticals,Inc. | ANDA |
| 66267-803 | Methocarbamol 750 mg/1 Tablet | NuCare Pharmaceuticals,Inc. | ANDA |
| 68071-4505 | Methocarbamol 750 mg/1 Tablet, Coated | NuCare Pharmaceuticals,Inc. | ANDA |
| 68071-4520 | Methocarbamol 500 mg/1 Tablet, Coated | NuCare Pharmaceuticals,Inc. | ANDA |
| 85477-101 | Methocarbamol 1000 mg/1 Tablet, Coated | Oncora Pharma, LLC | ANDA |
| 69584-611 | Methocarbamol 500 mg/1 Tablet | Oxford Pharmaceuticals, LLC | ANDA |
| 69584-612 | Methocarbamol 750 mg/1 Tablet | Oxford Pharmaceuticals, LLC | ANDA |
| 72789-428 | Methocarbamol 500 mg/1 Tablet | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 72789-398 | Methocarbamol 750 mg/1 Tablet | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 43063-905 | Methocarbamol 750 mg/1 Tablet, Coated | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 43063-903 | Methocarbamol 500 mg/1 Tablet, Coated | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 72789-397 | Methocarbamol 500 mg/1 Tablet | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 72789-429 | Methocarbamol 750 mg/1 Tablet | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 72789-110 | Methocarbamol 500 mg/1 Tablet, Film Coated | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 72789-012 | Methocarbamol 500 mg/1 Tablet, Film Coated | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 72789-021 | Methocarbamol 500 mg/1 Tablet, Film Coated | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 72789-022 | Methocarbamol 750 mg/1 Tablet, Film Coated | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 72789-041 | Methocarbamol 750 mg/1 Tablet, Film Coated | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 82982-038 | Methocarbamol 750 mg/1 Tablet, Coated | Pharmasource Meds, LLC | ANDA |
| 85509-1910 | Methocarbamol 500 mg/1 Tablet | PHOENIX RX LLC | ANDA |
| 85509-1341 | Methocarbamol 750 mg/1 Tablet, Film Coated | PHOENIX RX LLC | ANDA |
| 85509-1770 | Methocarbamol 750 mg/1 Tablet, Coated | PHOENIX RX LLC | ANDA |
| 85509-2910 | Methocarbamol 500 mg/1 Tablet | PHOENIX RX LLC | ANDA |
| 68788-8880 | Methocarbamol 500 mg/1 Tablet, Film Coated | Preferred Pharmaceuticals Inc. | ANDA |
| 68788-7980 | Methocarbamol 750 mg/1 Tablet | Preferred Pharmaceuticals Inc. | ANDA |
| 68788-8172 | Methocarbamol 750 mg/1 Tablet, Coated | Preferred Pharmaceuticals Inc. | ANDA |
| 68788-8213 | Methocarbamol 500 mg/1 Tablet, Coated | Preferred Pharmaceuticals Inc. | ANDA |
| 68788-8822 | Methocarbamol 500 mg/1 Tablet | Preferred Pharmaceuticals Inc. | ANDA |
| 68788-8867 | Methocarbamol 500 mg/1 Tablet, Film Coated | Preferred Pharmaceuticals Inc. | ANDA |
| 68788-8876 | Methocarbamol 750 mg/1 Tablet, Film Coated | Preferred Pharmaceuticals Inc. | ANDA |
| 68788-7973 | Methocarbamol 500 mg/1 Tablet | Preferred Pharmaceuticals, Inc | ANDA |
| 71205-375 | Methocarbamol 500 mg/1 Tablet | Proficient Rx LP | ANDA |
| 63187-019 | Methocarbamol 750 mg/1 Tablet | Proficient Rx LP | ANDA |
| 63187-087 | Methocarbamol 500 mg/1 Tablet | Proficient Rx LP | ANDA |
| 63187-130 | Methocarbamol 750 mg/1 Tablet | Proficient Rx LP | ANDA |
| 82804-955 | Methocarbamol 750 mg/1 Tablet | Proficient Rx LP | ANDA |
| 82804-954 | Methocarbamol 500 mg/1 Tablet | Proficient Rx LP | ANDA |
| 82804-273 | Methocarbamol 500 mg/1 Tablet | Proficient Rx LP | ANDA |
| 82804-121 | Methocarbamol 500 mg/1 Tablet | Proficient Rx LP | ANDA |
| 71205-068 | Methocarbamol 750 mg/1 Tablet, Coated | Proficient Rx LP | ANDA |
| 71205-103 | Methocarbamol 500 mg/1 Tablet, Film Coated | Proficient Rx LP | ANDA |
| 71205-167 | Methocarbamol 500 mg/1 Tablet, Coated | Proficient Rx LP | ANDA |
| 71205-285 | Methocarbamol 750 mg/1 Tablet, Film Coated | Proficient Rx LP | ANDA |
| 67296-2203 | Methocarbamol 750 mg/1 Tablet, Coated | Redpharm Drug | ANDA |
| 67296-2197 | Methocarbamol 500 mg/1 Tablet, Coated | Redpharm Drug | ANDA |
| 67296-2193 | Methocarbamol 500 mg/1 Tablet, Film Coated | Redpharm Drug | ANDA |
| 67296-1435 | Methocarbamol 500 mg/1 Tablet | Redpharm Drug, Inc. | ANDA |
| 70518-1723 | Methocarbamol 500 mg/1 Tablet, Coated | REMEDYREPACK INC. | ANDA |
| 70518-1738 | Methocarbamol 750 mg/1 Tablet, Coated | REMEDYREPACK INC. | ANDA |
| 70518-4472 | Methocarbamol 750 mg/1 Tablet | REMEDYREPACK INC. | ANDA |
| 70518-4501 | Methocarbamol 750 mg/1 Tablet, Coated | REMEDYREPACK INC. | ANDA |
| 70518-4603 | Methocarbamol 500 mg/1 Tablet, Coated | REMEDYREPACK INC. | ANDA |
| 25021-675 | Methocarbamol 100 mg/mL Injection, Solution | Sagent Pharmaceuticals | ANDA |
| 25021-689 | Methocarbamol 100 mg/mL Injection, Solution | Sagent Pharmaceuticals | ANDA |
| 70436-149 | Methocarbamol 100 mg/mL Injection | Slate Run Pharmaceuticals, LLC | ANDA |
| 43547-405 | Methocarbamol 500 mg/1 Tablet | Solco Healthcare LLC | ANDA |
| 43547-226 | Methocarbamol 750 mg/1 Tablet | Solco Healthcare LLC | ANDA |
| 70069-101 | Methocarbamol 100 mg/mL Injection | Somerset Therapeutics, LLC | ANDA |
| 85766-060 | Methocarbamol 750 mg/1 Tablet, Film Coated | Sportpharm LLC | ANDA |
| 60760-875 | Methocarbamol 750 mg/1 Tablet, Film Coated | St. Mary's Medical Park Pharmacy | ANDA |
| 60760-874 | Methocarbamol 500 mg/1 Tablet, Film Coated | St. Mary's Medical Park Pharmacy | ANDA |
| 60760-770 | Methocarbamol 750 mg/1 Tablet, Coated | St. Mary's Medical Park Pharmacy | ANDA |
| 60760-725 | Methocarbamol 750 mg/1 Tablet | St. Mary's Medical Park Pharmacy | ANDA |
| 60760-592 | Methocarbamol 500 mg/1 Tablet, Coated | St. Mary's Medical Park Pharmacy | ANDA |
| 73352-510 | Methocarbamol 1000 mg/1 Tablet, Coated | Trifluent Pharma LLC | ANDA |
| 76385-123 | Methocarbamol 500 mg/1 Tablet, Film Coated | UNICHEM PHARMACEUTICALS (USA), INC. | ANDA |
| 76385-124 | Methocarbamol 750 mg/1 Tablet, Film Coated | UNICHEM PHARMACEUTICALS (USA), INC. | ANDA |
| 87441-057 | Methocarbamol 500 mg/1 Tablet | Unit Dose Solutions, Inc. | ANDA |
| 87441-086 | Methocarbamol 500 mg/1 Tablet, Coated | Unit Dose Solutions, Inc. | ANDA |
| 72865-234 | Methocarbamol 750 mg/1 Tablet | XLCare Pharmaceuticals Inc. | ANDA |
| 72865-233 | Methocarbamol 500 mg/1 Tablet | XLCare Pharmaceuticals Inc. | ANDA |
Methocarbamol recalls
- D-0354-2025 Apr 16, 2025 · Class II · Ongoing
Lack of Assurance of Sterility: Media fill with bacterial contamination - D-0440-2024 Apr 17, 2024 · Class I · Ongoing
Presence of Particulate Matter
Frequently asked questions
What is Methocarbamol used for?
Methocarbamol Tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.
What are the side effects of Methocarbamol?
Adverse reactions reported coincident with the administration of methocarbamol include: Body as a whole: Anaphylactic reaction, angioneurotic edema, fever, headache Cardiovascular system: Bradycardia, flushing, hypotension, syncope, thrombophlebitis Digestive system: Dyspepsia, jaundice (including cholestatic jaundice), nausea and vomiting Hemic and lymphatic system: Leukopenia Immune system:… See the full label for the complete list.
Who makes Methocarbamol?
Methocarbamol is listed by 62 labelers in the FDA NDC directory, including A-S Medication Solutions, Advanced Rx of Tennessee, LLC, Advanced Rx Pharmacy of Tennessee, LLC, American Health Packaging.
Has Methocarbamol been recalled?
The FDA enforcement database lists 2 recalls for Methocarbamol, most recently D-0354-2025 (class ii): Lack of Assurance of Sterility: Media fill with bacterial contamination